Literature DB >> 25892660

Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease.

Pablo Martinez-Martin1, Carmen Rodriguez-Blazquez2, Maria João Forjaz3, Belén Frades-Payo4, Luis Agüera-Ortiz5, Daniel Weintraub6, Ana Riesco4, Monica M Kurtis7, Kallol Ray Chaudhuri8.   

Abstract

INTRODUCTION: In Parkinson's disease (PD), neuropsychiatric symptoms (NPS) can be particularly burdensome for caregivers. The main goal of this study was to assess the impact of NPS, assessed by means of a new specific scale, on caregiver burden.
METHODS: A sample of 584 pairs of PD patients and their primary caregivers was studied. Patients' NPS were measured with the Scale for Evaluation of Neuropsychiatric Disorders in PD (SEND-PD), and the Zarit Caregiver Burden Inventory was used to quantify caregiver burden. Three linear regression models were built to check factors associated with caregiver burden, one for the total sample and two for subgroups stratified by the presence of dementia.
RESULTS: The most frequent NPS were depression (in 66% of the sample), anxiety (65%) and mental fatigue (57%). Patients with dementia (n = 94; 16% of sample) consistently presented more NPS than patients without dementia (p < 0.001). On linear regression models, the main determinants of caregiver burden (for the total sample and the sample of patients without dementia) were SEND-PD dimensions mood/apathy and psychosis, PD-related disability and disease duration. For patients with dementia, the only significant caregiver burden determinants were SEND-PD psychosis and mood/apathy subscale scores.
CONCLUSIONS: NPS in PD are highly associated with and are determinants of caregiver burden, and are more prevalent and burdensome in patients with dementia. Detailed assessment and specific interventions aimed at NPS could alleviate caregiver burden.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Caregiver burden; Neuropsychiatric symptoms; Parkinson's disease

Mesh:

Year:  2015        PMID: 25892660     DOI: 10.1016/j.parkreldis.2015.03.024

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  50 in total

1.  The experience of care partners of patients with Parkinson's disease psychosis.

Authors:  Sneha Mantri; Emily Klawson; Steven Albert; Robyn Rapoport; Chelle Precht; Sarah Glancey; Margaret Daeschler; Eugenia Mamikonyan; Catherine M Kopil; Connie Marras; Lana M Chahine
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

Review 2.  Integrating Patient Concerns into Parkinson's Disease Management.

Authors:  Shen-Yang Lim; Ai Huey Tan; Susan H Fox; Andrew H Evans; Soon Chai Low
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

Review 3.  Neuropsychiatric Issues in Parkinson's Disease.

Authors:  Jeffrey W Cooney; Mark Stacy
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

Review 4.  Pimavanserin: A Novel Drug Approved to Treat Parkinson's Disease Psychosis.

Authors:  Amanda K Kitten; Sarah A Hallowell; Stephen R Saklad; Kirk E Evoy
Journal:  Innov Clin Neurosci       Date:  2018-02-01

5.  Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.

Authors:  Maria Jose Catalan; Jose Antonio Molina-Arjona; Pablo Mir; Esther Cubo; Jose Matias Arbelo; Pablo Martinez-Martin
Journal:  J Neurol       Date:  2018-03-20       Impact factor: 4.849

6.  Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)).

Authors:  Morgana Moretti; Vivian Binder Neis; Filipe Carvalho Matheus; Mauricio Peña Cunha; Priscila Batista Rosa; Camille Mertins Ribeiro; Ana Lúcia S Rodrigues; Rui Daniel Prediger
Journal:  Neurotox Res       Date:  2015-07-09       Impact factor: 3.911

7.  Interdisciplinary Home Visits for Individuals with Advanced Parkinson's Disease and Related Disorders.

Authors:  Jori Fleisher; William Barbosa; Meghan M Sweeney; Sarah E Oyler; Amy C Lemen; Arash Fazl; Mia Ko; Talia Meisel; Naomi Friede; Geraldine Dacpano; Rebecca M Gilbert; Alessandro Di Rocco; Joshua Chodosh
Journal:  J Am Geriatr Soc       Date:  2018-04-02       Impact factor: 5.562

Review 8.  Parkinson disease-associated cognitive impairment.

Authors:  Dag Aarsland; Lucia Batzu; Glenda M Halliday; Gert J Geurtsen; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub
Journal:  Nat Rev Dis Primers       Date:  2021-07-01       Impact factor: 52.329

Review 9.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

10.  Prevalence of Non-Motor Symptoms and Non-Motor Fluctuations in Parkinson's Disease Using the MDS-NMS.

Authors:  Carmen Rodriguez-Blazquez; Anette Schrag; Alexandra Rizos; K Ray Chaudhuri; Pablo Martinez-Martin; Daniel Weintraub
Journal:  Mov Disord Clin Pract       Date:  2020-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.